20 June 2013
Keywords: cilag, gains, european, nesiritide, rights, gmbh, international
Article | 08 August 2005
Cilag GmbH International, a Johnson & Johnson company, is to acquire European marketing and development rights to Noratak (nesiritide) from
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 August 2005
19 June 2013
© 2013 thepharmaletter.com